News

Epstein EMUC

EMUC18: Everything in prostate cancer pathology you were afraid to ask

Marking its 10th year, this year’s annual European Multidisciplinary Congress on Urological Cancers (EMUC18) will emphasise the synergies from multidisciplinary teamwork (MDT) to highlight that comprehensive cancer care is only possible when various experts work together to identify and...

EMUC18: Joint initiatives reinforce effective MDT in onco-urology

Multidisciplinary teamwork, although a widely-accepted practice in medicine, still has a long way to go in actual clinical and research work considering new challenges encountered by physicians such as the introduction of new diagnostic and treatment agents and their...

EMUC18: Costs and optimal PCa care- Finding the crucial balance

Across Europe the debate has begun on how to deliver uniform and quality care for prostate cancer (PCa) patients in the region, but healthcare experts and physicians are encountering deeply-rooted issues that range from financial costs, poor patient recruitment...

EMUC17: Using biomarkers in decision-making for RCC treatment

Renal cell carcinomas are among the most lethal in urological malignancies prompting doctors to search for tools such as biomarkers and other molecular techniques to distinguish aggressive diseases. With new research outcomes, physicians are hopeful that diagnosis and therapy...
Oncologist Dr. Andrea Necchi of the Fondazione Irccs Istituto Nazionale Dei Tumori in Milan

EMUC17: Bladder cancer- Challenges in immunotherapy

Immunotherapy is widely anticipated to offer a more prominent role in managing urological cancers but there are unresolved issues and obstacles particularly in the area of managing aggressive bladder cancer, according to experts. “Immunotherapy is likely to play a...
Prof. Anwar Padhani, radiologist, of the Paul Strickland Scanner Centre

EMUC17: Crucial need to standardize MRI use and reporting

There is an urgent need to standardize acquisition, interpretation and reporting of whole body Magnetic Resonance Imaging (MRI) to enable doctors to properly evaluate MRI’s impact on the clinical management of advanced prostate cancer (PCa). “There is a clear...

EMUC17: Examining key topics in urothelial carcinoma

Risk assessment and evaluation of disease extent remain crucial elements in the optimal treatment and management of upper tract urothelial carcinoma, according to experts who emphasise the need for doctors to conduct a better assessment of disease characteristics. “Treatment...

FALCON Workshop focuses on salvage intra-prostatic relapses

The European SocieTy for Radiotherapy & Oncology (ESTRO) organised the educational and multifunctional FALCON (Fellowship in Anatomic delineation and CONtouring) Workshop during the recently concluded 8th European Multidisciplinary Meeting on Urological Cancers (EMUC16). This year’s FALCON Workshop was a...